73 related articles for article (PubMed ID: 23838860)
41. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.
Kohonen-Corish MR; Tseung J; Chan C; Currey N; Dent OF; Clarke S; Bokey L; Chapuis PH
Int J Cancer; 2014 Jun; 134(12):2820-8. PubMed ID: 24259266
[TBL] [Abstract][Full Text] [Related]
42. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry.
Fietkau R; Zettl H; Klöcking S; Kundt G
Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
[TBL] [Abstract][Full Text] [Related]
43. Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades.
Fischer J; Hellmich G; Jackisch T; Puffer E; Zimmer J; Bleyl D; Kittner T; Witzigmann H; Stelzner S
Int J Colorectal Dis; 2015 Jun; 30(6):797-806. PubMed ID: 25922143
[TBL] [Abstract][Full Text] [Related]
44. Mortality trends from colorectal cancer in Chile.
Bellolio F; Donoso A; Molina ME; Miguieles R; Zuñiga A
Colorectal Dis; 2013 Jun; 15(6):761-2. PubMed ID: 23692079
[No Abstract] [Full Text] [Related]
45. Tumor DNA content in the prognosis of colorectal carcinoma.
Kokal W; Sheibani K; Terz J; Harada JR
JAMA; 1986 Jun; 255(22):3123-7. PubMed ID: 3702022
[TBL] [Abstract][Full Text] [Related]
46. [Malignant neoplasms of the colon and rectum in the G.D.R. (author's transl)].
Berndt H
Dtsch Z Verdau Stoffwechselkr; 1979; 39(6):265-74. PubMed ID: 546630
[TBL] [Abstract][Full Text] [Related]
47. Colorectal specialization and survival in colorectal cancer.
Hall GM; Shanmugan S; Bleier JI; Jeganathan AN; Epstein AJ; Paulson EC
Colorectal Dis; 2016 Feb; 18(2):O51-60. PubMed ID: 26708838
[TBL] [Abstract][Full Text] [Related]
48. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
Han SW; Lee HJ; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Int J Cancer; 2013 May; 132(9):2209-16. PubMed ID: 23034738
[TBL] [Abstract][Full Text] [Related]
49. The need to consider age and anatomic subsite when comparing sex-specific survival rates for colorectal cancer.
McMichael AJ
J Chronic Dis; 1982; 35(11):869-70. PubMed ID: 7142365
[No Abstract] [Full Text] [Related]
50. Age and mortality in colorectal cancer.
Houghton PW; Donaldson LA
Br J Surg; 1986 Oct; 73(10):862-3. PubMed ID: 3768661
[No Abstract] [Full Text] [Related]
51. Effect of sex and reproductive history on the survival of patients with colorectal cancer.
Koch M; McPherson TA; Egedahl RD
J Chronic Dis; 1982; 35(1):69-72. PubMed ID: 7068804
[TBL] [Abstract][Full Text] [Related]
52. Mortality analysis of colorectal carcinoma in Ireland. Time trends and an international comparison.
Harkin K; MacMahon B; Doyle JS; Kinsella IA
Ir J Med Sci; 1985 Sep; 154(9):343-7. PubMed ID: 4055318
[No Abstract] [Full Text] [Related]
53. Survival patterns from large bowel cancer in Hawaii.
Hirohata T; Nomura A; Rellahan W; Burch T; Harris D; Batten G
Hawaii Med J; 1977 Nov; 36(11):343-7. PubMed ID: 591310
[No Abstract] [Full Text] [Related]
54. Causation revisited.
Frank JW
J Clin Epidemiol; 1988; 41(5):425-6. PubMed ID: 3367171
[No Abstract] [Full Text] [Related]
55. Pattern makers mortality study.
Hearn S; Bond GG; Cook RR; Schneider EJ; Kolesar RC
J Occup Med; 1983 Oct; 25(10):719, 722. PubMed ID: 6631554
[No Abstract] [Full Text] [Related]
56. Defining colon cancer biomarkers by using deep learning.
Specogna AV; Sinicrope FA
Lancet; 2020 Feb; 395(10221):314-316. PubMed ID: 32007149
[No Abstract] [Full Text] [Related]
57. Colorectal cancer survival by location and microsatellite status: data from the Colon Cancer Family Registries and their implications.
Lynch PM
Dis Colon Rectum; 2013 Aug; 56(8):935-6. PubMed ID: 23838860
[No Abstract] [Full Text] [Related]
58. Colon and rectal cancer survival by tumor location and microsatellite instability: the Colon Cancer Family Registry.
Phipps AI; Lindor NM; Jenkins MA; Baron JA; Win AK; Gallinger S; Gryfe R; Newcomb PA
Dis Colon Rectum; 2013 Aug; 56(8):937-44. PubMed ID: 23838861
[TBL] [Abstract][Full Text] [Related]
59. Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry.
Gawlick U; Lu KC; Douthit MA; Diggs BS; Schuff KG; Herzig DO; Tsikitis VL
Am J Surg; 2013 May; 205(5):608-12; discussion 612. PubMed ID: 23592171
[TBL] [Abstract][Full Text] [Related]
60. Staging of colon and rectal cancer: from endoscopy to molecular markers.
Greene FL
Surg Endosc; 2006 Apr; 20 Suppl 2():S475-8. PubMed ID: 16544060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
